Cargando…

Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects

BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of major depression. Individuals with type 2 diabetes (T2DM) have a high prevalence of major depression and low levels of BDNF. We therefore explored whether the BDNF Val66Met polymorphism is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian-Xin, Li, He-Chao, Bai, Xue-Jun, Chang, Bao-Cheng, Li, Chun-Jun, Sun, Pei, Chen, Li-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765870/
https://www.ncbi.nlm.nih.gov/pubmed/23968401
http://dx.doi.org/10.1186/1744-9081-9-34
_version_ 1782283410216058880
author Zhou, Jian-Xin
Li, He-Chao
Bai, Xue-Jun
Chang, Bao-Cheng
Li, Chun-Jun
Sun, Pei
Chen, Li-Ming
author_facet Zhou, Jian-Xin
Li, He-Chao
Bai, Xue-Jun
Chang, Bao-Cheng
Li, Chun-Jun
Sun, Pei
Chen, Li-Ming
author_sort Zhou, Jian-Xin
collection PubMed
description BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of major depression. Individuals with type 2 diabetes (T2DM) have a high prevalence of major depression and low levels of BDNF. We therefore explored whether the BDNF Val66Met polymorphism is associated with co-morbid depression and whether depression affects the serum levels of BDNF in a Han Chinese subjects with T2DM. METHODS: A Total of 296 T2DM patients and 70 healthy volunteers (Health control, HC group) were recruited in this study. T2DM patients were divided into two subgroups: depressive diabetes group (DDM group, n = 64) and non-depressive diabetes group (NDDM group, n = 232), according to the presence or the absence of depression assessed by Center for Epidemiologic Studies Depression Scale (CES-D) and Patient Health Questionnaire-9 (PHQ-9). Val66Met polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP). Serum BDNF levels were measured by ELISA kit. RESULTS: In this study, 21.6% (64/296) patients with T2DM had depression. The BDNF Val66Met genotype distributions were statistically different among the three groups (χ(2) = 7.39, p < 0.05). DDM group carried the highest frequencies of Met allele (53.9%) compared to HC group (39.3%) and NDDM group (38.8%). Subjects with Met/Met had lowest serum BDNF levels (76.59 ± 5.12 pg/ml, F = 7.39, p < 0.05) compared to subjects with Val/Met (79.04 ± 5.19 pg/ml) and Val/Val (83.83 ± 3.97 pg/ml). Within T2DM group, it was also observed that the serum BDNF levels in DDM group were significantly lower than those in NDDM group (76.67 ± 5.35 vs. 79.84 ± 3.97 pg/ml, p < 0.05). In type 2 diabetes subjects, BDNF serum levels were significant correlations with genotypes (r = −0.346, p < 0.01), depression scores (r = −0.486, p < 0.01) and HbA1c (r = −0.168, p < 0.05). After adjustment for gender, HbA1c, BMI and numbers of complications, BDNF Val/Met genotype distributions (OR = 2.105, p < 0.05) and decreased serum BDNF levels (OR = 0.835, p < 0.01) were independently associated with depression in T2DM. CONCLUSIONS: The BDNF Val66Met polymorphism might be implicated in the pathogenesis of depression in T2DM by decreasing serum BDNF levels in Han Chinese Subjects.
format Online
Article
Text
id pubmed-3765870
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37658702013-09-08 Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects Zhou, Jian-Xin Li, He-Chao Bai, Xue-Jun Chang, Bao-Cheng Li, Chun-Jun Sun, Pei Chen, Li-Ming Behav Brain Funct Research BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of major depression. Individuals with type 2 diabetes (T2DM) have a high prevalence of major depression and low levels of BDNF. We therefore explored whether the BDNF Val66Met polymorphism is associated with co-morbid depression and whether depression affects the serum levels of BDNF in a Han Chinese subjects with T2DM. METHODS: A Total of 296 T2DM patients and 70 healthy volunteers (Health control, HC group) were recruited in this study. T2DM patients were divided into two subgroups: depressive diabetes group (DDM group, n = 64) and non-depressive diabetes group (NDDM group, n = 232), according to the presence or the absence of depression assessed by Center for Epidemiologic Studies Depression Scale (CES-D) and Patient Health Questionnaire-9 (PHQ-9). Val66Met polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP). Serum BDNF levels were measured by ELISA kit. RESULTS: In this study, 21.6% (64/296) patients with T2DM had depression. The BDNF Val66Met genotype distributions were statistically different among the three groups (χ(2) = 7.39, p < 0.05). DDM group carried the highest frequencies of Met allele (53.9%) compared to HC group (39.3%) and NDDM group (38.8%). Subjects with Met/Met had lowest serum BDNF levels (76.59 ± 5.12 pg/ml, F = 7.39, p < 0.05) compared to subjects with Val/Met (79.04 ± 5.19 pg/ml) and Val/Val (83.83 ± 3.97 pg/ml). Within T2DM group, it was also observed that the serum BDNF levels in DDM group were significantly lower than those in NDDM group (76.67 ± 5.35 vs. 79.84 ± 3.97 pg/ml, p < 0.05). In type 2 diabetes subjects, BDNF serum levels were significant correlations with genotypes (r = −0.346, p < 0.01), depression scores (r = −0.486, p < 0.01) and HbA1c (r = −0.168, p < 0.05). After adjustment for gender, HbA1c, BMI and numbers of complications, BDNF Val/Met genotype distributions (OR = 2.105, p < 0.05) and decreased serum BDNF levels (OR = 0.835, p < 0.01) were independently associated with depression in T2DM. CONCLUSIONS: The BDNF Val66Met polymorphism might be implicated in the pathogenesis of depression in T2DM by decreasing serum BDNF levels in Han Chinese Subjects. BioMed Central 2013-08-22 /pmc/articles/PMC3765870/ /pubmed/23968401 http://dx.doi.org/10.1186/1744-9081-9-34 Text en Copyright © 2013 Zhou et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhou, Jian-Xin
Li, He-Chao
Bai, Xue-Jun
Chang, Bao-Cheng
Li, Chun-Jun
Sun, Pei
Chen, Li-Ming
Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects
title Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects
title_full Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects
title_fullStr Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects
title_full_unstemmed Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects
title_short Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects
title_sort functional val66met polymorphism of brain-derived neurotrophic factor in type 2 diabetes with depression in han chinese subjects
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765870/
https://www.ncbi.nlm.nih.gov/pubmed/23968401
http://dx.doi.org/10.1186/1744-9081-9-34
work_keys_str_mv AT zhoujianxin functionalval66metpolymorphismofbrainderivedneurotrophicfactorintype2diabeteswithdepressioninhanchinesesubjects
AT lihechao functionalval66metpolymorphismofbrainderivedneurotrophicfactorintype2diabeteswithdepressioninhanchinesesubjects
AT baixuejun functionalval66metpolymorphismofbrainderivedneurotrophicfactorintype2diabeteswithdepressioninhanchinesesubjects
AT changbaocheng functionalval66metpolymorphismofbrainderivedneurotrophicfactorintype2diabeteswithdepressioninhanchinesesubjects
AT lichunjun functionalval66metpolymorphismofbrainderivedneurotrophicfactorintype2diabeteswithdepressioninhanchinesesubjects
AT sunpei functionalval66metpolymorphismofbrainderivedneurotrophicfactorintype2diabeteswithdepressioninhanchinesesubjects
AT chenliming functionalval66metpolymorphismofbrainderivedneurotrophicfactorintype2diabeteswithdepressioninhanchinesesubjects